Form 8-K - Current report:
SEC Accession No. 0001193125-24-274844
Filing Date
2024-12-11
Accepted
2024-12-11 06:30:30
Documents
13
Period of Report
2024-12-11
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d903999d8k.htm   iXBRL 8-K 25966
  Complete submission text file 0001193125-24-274844.txt   148412

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA scph-20241211.xsd EX-101.SCH 2882
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20241211_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20241211_pre.xml EX-101.PRE 11283
15 EXTRACTED XBRL INSTANCE DOCUMENT d903999d8k_htm.xml XML 3633
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 241540102
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)